Piper Jaffray Companies has hired Stuart C Harvey Jr (pictured) as a partner in the Piper Jaffray merchant banking group. The group manages private equity investments in commercial businesses with strong growth prospects. Harvey previously served as a managing director at Piper Jaffray from 1993-2003, and will be rejoining the firm
WuXi PharmaTech (Cayman) Inc (WuXi) has entered into a definitive Agreement and Plan of Merger with New WuXi Life Science Limited (Parent) and WuXi Merger Limited (Merger Sub), a wholly owned subsidiary of Parent. Pursuant to the Merger Agreement, Parent will acquire the Company for cash consideration equal to USD5.75 per
Amr Helal has joined Duet – CI Capital, a joint-venture between alternative asset manager Duet Group and Egyptian investment bank CI Capital, from the Abraaj Group to lead the Duet – CI Capital Egypt Opportunities Fund. The Egypt Opportunities Fund is a USD 300 million private equity fund dedicated to
Global law firm White & Case has expanded its Nordic private equity capabilities with the addition of Johan Steen (pictured) as a new partner in Stockholm. “The Nordic private equity market has been consistently one of the most active in Europe and is home to some of the world’s most
UK-based Loyalty Bay has raised USD1 million in a late seed funding round led by Talis Capital with Howzat Partners, NEON Adventures, Chris Mairs and Richard Verney all participating. Matus Maar has joined the board as Investor Director. Loyalty Bay enables businesses to reward and incentivise any action (i.e. sale,
Restoration Partners, the London-based technology-focused merchant bank, has secured start-up funding for We Are Briqs. A member of the Restoration Alpha Angels network, who is an experienced and successful investor in Fintech companies, has provided the backing. We Are Briqs delivers white-label, plug-and-play solutions for retail banking. Their products create
Inflexion has sold its Partnership Capital investment in Rhead Group (Rhead), a technical professional services consultancy, to Costain Group PLC (Costain) in a transaction valued at GBP36 million. Acquisitive growth and diversification were the focus of our partnership. Inflexion supported four transformational add-on acquisitions broadening Rhead’s offering, customer base and
Concept Life Sciences, a scientific laboratory and consultancy group has acquired CXR Biosciences as it continues its acquisition spree in the fast-growing CRO market. This marks its fourth acquisition since the Manchester-headquartered company was formed last year following investment from European private equity firm Equistone Partners Europe. The group acquired
CXR Biosciences Limited, (CXR) the Dundee-based investigative and exploratory toxicology business, has been sold by its shareholders – including Archangel Investors and Scottish Investment Bank – to UK-based Concept Life Sciences, the growing life sciences, scientific laboratory and consultancy group. CXR is a leading investigative toxicology business. Its in-house expertise
Affinia Group, including its global filtration operations, but excluding its Affinia South America (ASA) operations, will be sold to MANN+HUMMEL. Based in Ludwigsburg, Germany, MANN+HUMMEL is a privately-held global filtration expert offering filtration solutions to original equipment and aftermarket customers in both the automotive and industrial sectors. "Our agreement
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
